Kwesst Announces Market Introduction and Progress of Phantom Electronic Decoy

  • Teaming in progress with global defense contractor for quantity requirement
  • U.S. military selects PhantomTM for showcase demonstration
  • Demonstrations, requests for pricing, underway with other NATO customers
  • Growing suite of patents, strong IP protection

KWESST Micro Systems Inc. (TSXV: KWE) (OTCQB: KWEMF) ("KWESST" or "the Company") today announced several favorable developments regarding the introduction to market of its PhantomTM electronic battlefield decoy. PhantomTMis a programmable radio frequency ("RF") generator that can mimic the electronic communications of NATO forces, thus fooling adversaries as to their location.

PhantomTM also provides the ability to see radio frequency energy of both adversaries and friendly forces and gives the user a high-fidelity planning capability for optimal placement for maximum effectiveness. Finally, PhantomTM provides a training function that allows NATO forces to "practice" operating in Electronic Warfare ("EW") environments.

Requirement for PhantomTM on armored vehicles

As part of discussions with large defense contractors, the Company announced that it is in advanced negotiations with a global defense contractor to provide PhantomTM units as part of the contractor's tender for armored vehicles to a large NATO customer. Inclusion of an electronic battlefield decoy technology, like KWESST's PhantomTM on the vehicles was requested by the NATO customer as part of the tender. Should the defense contractor win the tender, it is expected that the accompanying requirement for PhantomTM will result in a contract worth more than USD $40M for KWESST depending on the number of vehicles purchased, with initial revenue in the current fiscal year and ramping up in 2023 and 2024.

Showcase demonstration for U.S. military

The U.S. Department of Defense ("DoD") has requested a showcase demonstration of PhantomTM at its upcoming signature, invitation-only event "Silent Swarm 22" next summer for advanced Electro Magnetic Spectrum Operations ("EMSO"). In July 2021, PhantomTM was showcased by invitation-only to a U.S. Special Operations Command ("USSOCOM") technical exercise, where KWESST designers and engineers engaged with the Special Operations community in a collaborative environment. This led directly to discussions and negotiations with three large defense contractors regarding potential go-to-market partnerships across a variety of rapidly emerging requirements and programs forelectronic decoys. The U.S. DoD also expressed interest in an additional, small, disposable version of PhantomTM for use by Special Forces, pursuant to which KWESST has developed a concept model (far right, below). PhantomTMis also fully integrated with ATAK (Android Team Awareness Kit, center, below).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7366/98406_f5a72fa2b4d13ad6_002.jpg

To view an enhanced version of this graphic, please visit:
https://orders.newsfilecorp.com/files/7366/98406_f5a72fa2b4d13ad6_002full.jpg

An earlier prototype version of PhantomTM was procured and successfully trialed in U.S. military exercises prior to KWESST's acquisition of the technology as announced June 15, 2020. The latest version is more compact, with vastly greater capability, and is soldier-portable or can be deployed by Unmanned Aerial Systems ("UAVs" or "drones").

Demonstrations, pricing requests from other customers

The Company reported that demonstration units of PhantomTM are available and are being deployed in customer evaluations, with two additional U.S. military agencies already requesting pricing.

Pathways to market and potential

"Together, these developments mean significant growing interest in the PhantomTM product suite and multiple pathways to market," said Jeff MacLeod, KWESST's Founder, President and CEO, who added, "Initial sales are expected in the first quarter of our current fiscal year ending December 31st". Based on internal research and customer discussions, the Company estimates the market for a system like PhantomTM to be worth several hundred million dollars in the U.S. alone."

Intellectual property ("IP")

KWESST previously announced the award of two U.S. patents, both titled: Programmable Multi-Waveform RF Generator for Use as Battlefield Decoy. One patent focuses on the technological phenomenology (how it works) and the other focuses on methods of employment and concepts (how it is best used). The Company continues to expand its IP protection of PhantomTM, with two additional patents currently pending. "We believe this constitutes strong IP protection, and the flexible system architecture allows for rapid configuration at any scale for any given customer or requirement," concluded MacLeod.

About KWESST

KWESST develops and commercializes breakthrough next-generation tactical systems that meet the requirements of security forces and personal defense for overmatch capability against adversaries. The company's current portfolio of unique proprietary offerings include: its signature TASCSTM (Tactical Awareness and Situational Control System) for real-time awareness and targeting information from any source (including drones) streamed directly to users' smart devices and weapons; the autonomous GreyGhostTM soldier-portable micro drone missile system that defends against small hostile drones including swarms using high-speed kinetic impact; a Ground Laser Defence system to counter the emerging threat of weaponized lasers against personnel; and, the PhantomTMelectronic battlefield decoy system to mask the electromagnetic signature of friendly forces with decoy signatures at false locations to deceive and confuse adversaries. All systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems including Frontline, Edge, Killswitch and all versions of the ATAK Tactical Awareness. KWESST also has developmental "smart ordnance" projects including its "Shot Counter" system, which records the number and type of rounds fired, for optimized firearms maintenance and performance, and a unique non-lethal Low Energy Cartridge (LEC) system with application across all segments of the non-lethal market. The Company is headquartered in Ottawa, Canada, with representative offices in Washington, DC, London, UK and Abu Dhabi, UAE. KWESST trades on the TSX Venture Exchange under the symbol KWE and on the U.S. OTCQB under the symbol KWEMF.

Contact: Jason Frame, Investor Relations: frame@kwesst.com

For more information, please visit https://kwesst.com/

Cautionary Note Regarding Forward-Looking Statements

This news release includes certain "forward-looking statements" under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the expected size of the PhantomTM contract should the global defense contractor win the tender for the armored vehicles . Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. KWESST disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/98406

News Provided by Newsfile via QuoteMedia

The Conversation (0)
SEC website on phone screen.

SEC Reopens Investigation on Neuralink and Musk’s Twitter Deal

The US Securities and Exchange Commission (SEC) has reopened its investigation into Neuralink, Elon Musk’s brain-implant company, alongside a probe into Musk’s acquisition of Twitter, now rebranded as X.

A letter from Musk’s lawyer, Alex Spiro, disclosed the development on Thursday (December 12), raising questions about the ongoing legal disputes between Musk and the SEC, according to a Reuters report.

The letter, addressed to outgoing SEC Chair Gary Gensler, outlines the reopening of the Neuralink investigation and a settlement demand regarding the Twitter takeover, which happened in 2022.

Keep reading...Show less
Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Spearmint More Than Doubles the Acreage of the George Lake South Antimony Project in New Brunswick, Canada

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to announce that it has more than doubled the acreage on the recently acquired George Lake South Antimony Project in New Brunswick, Canada. This project now consists of 4,722 contiguous acres prospective for antimony.

James Nelson, President of Spearmint, stated, "In light of the recent ban of antimony by China to the USA, we made this strategic acquisition increasing the size of the George Lake South Antimony Project. Management feels that antimony will be one of the most sought after resources in 2025 and we plan to pursue this space with vigor and are currently evaluating additional projects. Management is formulating a plan on the George Lake South Antimony Project, and management also intends to update the market on Spearmint's crypto diversification plan in the near future as well. These are truly exciting times for Spearmint and Spearmint shareholders."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Spearmint Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike

Spearmint Announces Arrangements to Address Mailing Delays Resulting from Canada Post Strike

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to provide an update to shareholders on the impact of the strike by the Canadian Union of Postal Workers on the Company's ability to comply with its obligations to deliver to shareholders its financial statements and related disclosure and proxy-related materials in respect of the Company's annual general meeting of shareholders (the "Meeting") scheduled to be held at Cozen O'Connor LLP - 550 Burrard Street, Suite 2501, Vancouver, B.C., on Thursday, Dec. 19, 2024, at 10 a.m. PST.

James Nelson, President of Spearmint stated, "We want all of our shareholders to be aware of the current situation as there are many exciting events occurring for Spearmint in the short and medium term."

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech's THT Cancer Studies Demonstrates Strong Efficacy in Third Preclinical Study and Plans for First-in-human Early Feasibility Study

Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company", "Sona") announces results from its most recent preclinical study of its Targeted Hyperthermia Therapy ("THT") which uses the Company's patented, biocompatible gold nanorods ("GNRs") to treat certain solid cancer tumors, shrinking them and acting as an immune stimulator. Building on its success in melanoma and breast cancer studies, the Company's third preclinical efficacy study was conducted in an immunologically 'cold' colorectal cancer model ("CT26"), a model that represents the majority of human colon cancers, which do not typically respond to current standard of care immunotherapies.

In this preliminary study, whereas no mice that were given standard immunotherapy alone showed any response, 100% of mice in the THT treatment group responded to the same immunotherapy with 50% (4 out of 8) of those tumors eliminated within 12 days of treatment, as shown by the green line in Figure 1, below.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
RETRANSMISSION: Spearmint Comments on China's Ban of Critical Mineral Exports to the USA, including Antimony

RETRANSMISSION: Spearmint Comments on China's Ban of Critical Mineral Exports to the USA, including Antimony

Spearmint Resources Inc. (CSE: SPMT) (OTC Pink: SPMTF) (FSE: A2AHL5) (the "Company" or "Spearmint") wishes to comment on yesterday's announcement of China banning exports of critical minerals including antimony to the United States. As trade tensions escalate between the USA and China, this move clearly emphasizes the urgent need for Western nations to secure reliable long-term sources of these critical minerals which are now at the forefront of the global supply chain crisis.

Antimony is an essential component in semi-conductors, battery storage technology, and has several military applications. Prices of antimony trioxide in Rotterdam had soared by 228% since the beginning of the year to $39,000 a metric ton on Nov. 28, data from information provider Argus showed(1). The move is a considerable escalation of tensions in supply chains where access to raw material units is already tight in the West(1).

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Announces Establishment of Advisory Board and Appointment of Travel Industry Expert, Mr. John Kirk

Syntheia Corp. ("Syntheia" or the "Company") (Syntheia.ai), CSE SYAI, Syntheia, a Canadian leader in conversational AI SaaS, is pleased to announce the establishment of its new Advisory Board. The Advisory Board will collaborate with management and the board of directors to enhance the Company's strategic direction, provide expert guidance on its commercial initiatives, offer industry insights, and shape and accelerate innovations.

As the inaugural member of the Advisory Board, Syntheia welcomes Mr. John Kirk, a leader in the travel industry. The travel sector represents a potentially significant growth market for the Company's technology.

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×